These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Sex differences in anti-allodynic, anti-hyperalgesic and anti-edema effects of Δ(9)-tetrahydrocannabinol in the rat. Craft RM, Kandasamy R, Davis SM. Pain; 2013 Sep 01; 154(9):1709-1717. PubMed ID: 23707295 [Abstract] [Full Text] [Related]
13. Intrathecal Actions of the Cannabis Constituents Δ(9)-Tetrahydrocannabinol and Cannabidiol in a Mouse Neuropathic Pain Model. Casey SL, Mitchell VA, Sokolaj EE, Winters BL, Vaughan CW. Int J Mol Sci; 2022 Aug 03; 23(15):. PubMed ID: 35955774 [Abstract] [Full Text] [Related]
14. Cannabis constituent synergy in a mouse neuropathic pain model. Casey SL, Atwal N, Vaughan CW. Pain; 2017 Dec 03; 158(12):2452-2460. PubMed ID: 28885457 [Abstract] [Full Text] [Related]
15. Behavioral Effects of Vaporized Delta-8 Tetrahydrocannabinol, Cannabidiol, and Mixtures in Male Rats. Durbin DJ, King JM, Stairs DJ. Cannabis Cannabinoid Res; 2024 Apr 03; 9(2):601-611. PubMed ID: 36802211 [Abstract] [Full Text] [Related]
18. Assessment of Orally Administered Δ9-Tetrahydrocannabinol When Coadministered With Cannabidiol on Δ9-Tetrahydrocannabinol Pharmacokinetics and Pharmacodynamics in Healthy Adults: A Randomized Clinical Trial. Zamarripa CA, Spindle TR, Surujunarain R, Weerts EM, Bansal S, Unadkat JD, Paine MF, Vandrey R. JAMA Netw Open; 2023 Feb 01; 6(2):e2254752. PubMed ID: 36780161 [Abstract] [Full Text] [Related]